Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr

Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr

By: IPP Bureau

Last updated : July 30, 2025 10:24 am



Ajanta Pharma has reported total income of Rs. 1,328.98 crores during the period ended June 30, 2025


Ajanta Pharma Limited has reported consolidated financial results for the period ended June 30, 2025.

Ajanta Pharma has posted net profit of Rs. 255.34 crores for the period ended June 30, 2025 as against net profit of Rs. 225.26 crores for the period ended March 31, 2025.  The company posted net profit of Rs. 245.77 crores for the period ended June 30, 2024.

Ajanta Pharma has reported total income of Rs. 1,328.98 crores during the period ended June 30, 2025 as compared to Rs. 1,188.52 crores during the period ended March 31, 2025. The company reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024.

Ajanta Pharma Limited

First Published : July 30, 2025 12:00 am